跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要围绕随机试验主要终点的平均处理效应及其精度展开。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Jack M. Wolf
David M. Vock

结合协变量调整与次要终点信息提高随机试验精度

研究问题
在随机试验中,已调整基线协变量后,借用次要终点信息能否进一步提高主要终点平均处理效应的估计精度?
方法与思路
作者将基线协变量纳入单因子结构方程框架,再通过交叉验证模型平均,结合该估计与常规协变量调整估计。
材料陈述的贡献
摘要称模型正确时借用终点提高效率;模型平均缓解错设影响,应用中较单纯协变量调整获得百分之十三的精度改善。
阅读关注点
核对跨终点借用信息所需假设、结构方程约束、模型平均权重选择,以及精度定义和严重错设下的覆盖率。
阅读边界
这是 arXiv 预印本,同行评审及接收未核实;作者明确指出错设可能导致偏差与欠覆盖,模型平均也未完全消除风险。

原文摘要

Background/Aims: Adjustment for prognostic baseline covariates can improve precision in randomized trials. Previous work has shown that jointly modeling primary and secondary endpoints can yield additional precision by borrowing information across endpoints. We investigated whether these approaches can be combined to achieve efficiency gains beyond those obtained through covariate adjustment alone. Methods: We extended a previously proposed one-factor structural equation modeling framework for borrowing information from secondary endpoints to incorporate baseline covariates while retaining the average treatment effect on the primary endpoint as the estimand. To mitigate sensitivity to model misspecification, we combined this estimator with a conventional covariate-adjusted estimator using cross-validated model averaging. We evaluated operating characteristics in simulations and applied the methods to a randomized trial of very low versus normal nicotine content cigarettes. Results: When the structural equation model was correctly specified, endpoint borrowing improved efficiency beyond conventional covariate adjustment across all simulated settings. Model misspecification could induce bias and undercoverage. Model averaging reduced bias and improved coverage relative to the structural equation model estimator, although coverage remained imperfect under severe misspecification. In the trial application, the model-averaged estimate was 21% more precise than the unadjusted estimate and 13% more precise than covariate adjustment alone. Conclusion: Secondary endpoints can contribute meaningful information about the average treatment effect on a primary endpoint even after baseline covariates have been incorporated. These gains require stronger assumptions than conventional covariate adjustment; model averaging provides a practical compromise between efficiency and robustness.

笔记与分组
相关领域论文